Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Conatus Pharmaceutic (NASDAQ: CNAT)

$8.26 USD $0.74 (9.84%)
Last Price $8.26
Net Change $0.74 (9.84%)
Bid $7.93
Ask Price $12
Open Price $7.58
Previous Close Price $7.52
High Price $8.47
Low Price $7.54
Number of Trades 5,623
Volume 1,675,162
Fifty Two Week High $8.47 (2017-04-26)
Fifty Two Week Low $1.45 (2016-11-04)
Average Daily Volume 672,471
Share Outstanding 26,170 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $-0.35 (2017-03-15)
2nd Quarter Earnings $-0.31 (2016-11-08)
3nd Quarter Earnings $-0.3 (2016-08-03)
4th Quarter Earnings $-0.35 (2016-05-05)
PE Ratio $0
EPS Growth $49.31
Recent Earnings $-0.35
Annual EPS $-1.31
Last Quarter EPS $
Market Capitalization $0.22B
Insider Shareholders % 0.285%
Annual Revenue $0B
No. Shares Outstanding 26,170
Inst. Shareholder % 17.02%
Annual Net Income $0B
TTM Net Profit Margin $100.23
1-Year Return 155.78%
3-Year Return 23.08%
5-Year Return -20.84%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 49.310001%
Dividends per Share $
Stock Split Ratio
Beta 1.35
Conatus Pharmaceuticals, Inc. is a biotechnology company. It is focused on developing and commercializing medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. Conatus Pharmaceuticals, Inc. is headquartered in San Diego, California.

CNAT News & Stock Updates